MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness. Venkatadri comes to MBI from monoclonal
MBI has named Bobba Venkatadri as president and COO, the San Diegoultrasound contrast developer announced last week. Venkatadritakes the place of Vincent Frank, who passed away in August aftera lengthy illness.
Venkatadri comes to MBI from monoclonal antibody developerCentocor, where he served as executive vice president of the company'spharmaceutical division. He was instrumental in restructuringCentocor and in building strategic alliances and managing R&D,according to MBI.
In other news, MBI earlier this month said the Federal TradeCommission has cleared its new distribution and investment agreementwith Mallinckrodt Medical (SCAN 9/13/95).
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.